Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Clinical characteristics, risk factors, course, and outcome of disease

2018 ◽  
Vol 66 (5) ◽  
pp. e27594 ◽  
Author(s):  
Stavroula Anastasopoulou ◽  
Mats A. Eriksson ◽  
Mats Heyman ◽  
Chen Wang ◽  
Riitta Niinimäki ◽  
...  
Keyword(s):  
Risk Factors ◽  
Acute Lymphoblastic Leukemia ◽  
Posterior Reversible Encephalopathy Syndrome ◽  
Clinical Characteristics ◽  
Lymphoblastic Leukemia ◽  
Posterior Reversible Encephalopathy ◽  
Reversible Encephalopathy

scholarly journals Posterior Reversible Encephalopathy Syndrome During Acute Lymphoblastic Leukemia Treatment

2021 ◽  
Author(s):  
Sıla Atamyıldız ◽  
Eda Ataseven ◽  
Cenk Eraslan ◽  
Mehmet Kantar
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Posterior Reversible Encephalopathy Syndrome ◽  
Lymphoblastic Leukemia ◽  
Altered Mental Status ◽  
Acute Onset ◽  
Neurological Damage ◽  
Posterior Reversible Encephalopathy ◽  
Leukemia Treatment ◽  
Reversible Encephalopathy ◽  
Reversible Condition

Posterior reversible encephalopathy syndrome (PRES) is a clinical and radiological syndrome, characterized by acute onset of headache, altered mental status, visual impairment, nausea, vomiting, seizure, and hypertension. PRES is a reversible condition if it is recognized early, but neurological damage or even death may occur. Herein, we present two cases of ALL who developed PRES during their induction therapy and a literature review of PRES.

Sign in / Sign up

Export Citation Format

Share Document